Nordic Nanovector: Share Options Granted, Including Options to Primary Insiders
Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, announces that the Board of Directors of Nordic Nanovector ASA („Nordic …